共 50 条
- [2] Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML) [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
- [6] AML-068- Survival Differences in Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine (Oral-AZA) as Maintenance and Those Eligible but Not Treated in a US Electronic Health Record (EHR) Database (vol 23S1, S1-S593, 2023) [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (03): : 203 - 204